Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.
about
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationEffectiveness of systematic screening for the detection of atrial fibrillationCatheter ablation for paroxysmal and persistent atrial fibrillationFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationEffectiveness of systematic screening for the detection of atrial fibrillationFactor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationCatheter ablation for paroxysmal and persistent atrial fibrillationSystematic screening for the detection of atrial fibrillationAtrial fibrillation and sleep-disordered breathingCardiomyocyte Remodeling in Atrial Fibrillation and Hibernating Myocardium: Shared Pathophysiologic Traits Identify Novel Treatment Strategies?The role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directionsImplementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after studyCardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studiesLeft Atrial Substrate Modification Targeting Low-Voltage Areas for Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta-Analysis.Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns.Use of an interdisciplinary, participatory design approach to develop a usable patient self-assessment tool in atrial fibrillationA common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical recordsCardiovascular risk profile and management of atrial fibrillation in India: Real world data from RealiseAF surveyThe Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort DataThe association between pneumococcal pneumonia and acute cardiac events.Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Quality of Life, Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation.An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).Atrial fibrillation in congestive heart failure.A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study.Anticoagulation management in remote primary careTrends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trialsOmega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes.QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM studyTroponin utilization in patients presenting with atrial fibrillation/flutter to the emergency department: retrospective chart reviewImpact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study.Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registryLKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process.Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
P2860
Q24187110-F2051563-375A-4A6A-B689-90AE35B38DAFQ24197643-B7E5711B-1B73-48A0-BAC4-64464D7849EEQ24197923-16C1B039-5A8A-407A-BA6F-C12CC244E4ABQ24200210-12D99713-2515-4325-A062-3AA69D799BE8Q24200497-6863F7F1-59D6-47F8-A627-F79E4B4D0571Q24203942-2A9B7C98-3733-48AD-A91E-1E852AE198A7Q24234397-A71EC81C-F9BB-4936-A6C1-9763294C9B3EQ24243067-9C87D884-3390-4D0D-B126-887525B0F5EFQ24243337-AE6251C1-7D66-4E40-9095-BBADDC9243B8Q26471549-8DB6F549-99AD-4B0B-8F70-289C20175766Q26770269-848CC7CB-D114-4321-A5A8-AB5829BB3D1FQ26801890-36A900FF-23CE-4399-BE02-C2609A4341F2Q26822583-D318B08D-0BDA-410C-B5A9-767E54E97456Q28219345-ED7986C3-AD85-43E0-80D5-91583E699312Q28743162-F3C7B00E-520B-4021-9210-005E18874C66Q30239809-C52CCE90-980C-4B1E-8F01-14608AE78958Q30497538-1676B983-1B78-43AA-8914-556242D51365Q30557089-DB9F0EB7-1AE5-4A62-82C1-DDDC15DF44E7Q30886141-0E083088-B245-49D0-8C8E-3FB57E92D86CQ31138544-A0B19346-FC61-4CA2-812D-58F362576684Q31159143-D30AF64F-F482-4F6B-B023-3630DBAF2F2CQ33288215-3E6BDA5F-6894-451A-98A2-83CB89483959Q33553902-E2A15BFA-4128-40F9-AF65-71C4C54BB32CQ33585619-137BD451-D51B-4D73-A6EF-440493A828B1Q33811339-7FE32000-43C9-4586-B90A-74FA68FBD1E5Q33940724-1743ABDB-6360-4270-9E16-E925E4B24B6CQ33954432-F8693427-0703-43C2-A7A9-6C4F46536FCEQ34018990-22C6C2A5-032A-4550-8E6C-2C2FA18CD579Q34245296-4D5EF7E6-3C1E-4CB5-A4C2-5A23F2B4952FQ34417212-CFCE9E9E-6DD8-47E4-A22D-EF47C149AA05Q34653998-D83F2072-6D88-4B61-85DB-10C5A9B2021AQ34694265-7770EEBD-7CAD-4C19-9EF1-3A29CD317EC7Q34887291-2DD0387A-B67A-4DA8-A43C-F03119EB9065Q35009817-65C35BDA-71A2-4314-B009-D5FE6C99A0FAQ35078081-800F8A58-3412-4272-B0FD-265AAAD0C0D5Q35143132-0F884969-3768-46EC-B8EF-4F1A23C7B857Q35225444-574E5A88-6C0A-4EBD-B3B1-0644040FA1E3Q35226363-BD54A844-C696-49E1-81D4-0F8D37D7704FQ35354278-A1CA3741-CD19-4ADC-AF7B-131C1A203759Q35526930-236807E1-FFF3-4295-9FDD-6BB81A7FF24F
P2860
Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Increasing trends in hospitali ...... ations for primary prevention.
@en
Increasing trends in hospitali ...... ations for primary prevention.
@nl
type
label
Increasing trends in hospitali ...... ations for primary prevention.
@en
Increasing trends in hospitali ...... ations for primary prevention.
@nl
prefLabel
Increasing trends in hospitali ...... ations for primary prevention.
@en
Increasing trends in hospitali ...... ations for primary prevention.
@nl
P921
P1433
P1476
Increasing trends in hospitali ...... ations for primary prevention.
@en
P2093
Janet B Croft
Wendy A Wattigney
P304
P356
10.1161/01.CIR.0000083722.42033.0A
P407
P577
2003-07-28T00:00:00Z